Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $292 Million
- Q3 2024
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 247,820 shares of CLDX stock, worth $6.53 Million. This represents 2.89% of its overall portfolio holdings.
Number of Shares
247,820
Previous 249,220
0.56%
Holding current value
$6.53 Million
Previous $9.22 Million
8.73%
% of portfolio
2.89%
Previous 3.28%
Shares
22 transactions
Others Institutions Holding CLDX
# of Institutions
198Shares Held
63.8MCall Options Held
212KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$213 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$98.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$89.3 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$87.6 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.23B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...